新耀萊(00970.HK) : 法院就原訴傳票作出裁定前 不會配售換股債
新耀萊(00970.HK)公布,有關針對該公司及另外八名被告人的臨時禁制令,上周五(29日)在高等法院進行延續臨時禁制令之原訴傳票聆訊上,法院已發出進一步進行原訴傳票之指示。
公司承諾,在法院就原訴傳票作出裁定或作出進一步頒令前,不會採取任何步驟執行有關可換股債券配售協議任何行動,或向任何承配人發行可換股債券。法院頒令將原訴傳票之實質辯論,押後至不早於今年12月8日進行。公司將會遵照上市規則,於適當時候另行發表有關原訴傳票之公佈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.